Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accuracy, adhere, aggravating, Allegretti, AMR, annum, antibacterial, automated, backdrop, beneficiary, bioplatform, Britton, brkp, Cambridgepark, categorized, CCF, CIO, classification, CLIA, climate, conversion, coordinate, CSF, deceptive, delete, depleted, disaggregated, disaster, dispensed, divided, Dlalal, DPF, drawn, editor, Enterobacteriaceae, Enterococcaceae, enterprise, Erroneously, ESKAPE, excessive, exhaustion, extinguishment, Feuerstadt, floor, fostering, freestanding, Guaranty, Hart, HCP, Hedging, IDWeek, Inspector, inventory, Irvine, Israel, lieu, longevity, macro, Marella, margin, messaging, Metagenomi, morale, Network, Nexium, NIH, NIST, Oaktree, obsolescence, occasionally, online, OTC, Overnight, paradigm, Peled, phenotype, practitioner, PREA, Prilosec, programmatic, prompt, proposition, PSU, QPPV, ratably, realign, recalculating, recapitulated, reclassified, reconciling, reinforcing, route, run, running, saving, send, sending, sequelae, simulation, SOFR, Staphylococcaceae, Straub, stream, Streptococcaceae, supplier, taxonomic, Thorell, trailing, unadvertised, undergone, underway, unlawful, unmarketability, VOWST, Voyage, warehouse, Windsor
Removed:
advancing, affinity, Aimmune, Albany, Anderson, AstraZeneca, augmenting, Australasia, Axcella, Behar, bleeding, Boehringer, checkpoint, complement, Composite, consummation, continuity, CPRA, distancing, endoscopic, enhanced, enrolling, EPFL, exceeded, Forsyth, France, FTE, gaining, Gleevec, graft, graph, half, Hampshire, headcount, imatinib, Ingelheim, initiating, INSEAD, Kappelman, lien, liquidated, Los, magnitude, managerial, mapping, MD, Mechanical, mechanistic, MedImmune, Meryl, misrepresentation, month, monthly, Myeloma, NECAR, negotiate, Neon, observe, permission, pilot, Piper, pledged, pre, recommend, rectal, Region, reinvestment, remote, renegotiate, rescinded, Sandler, shipping, Sidney, simultaneously, situation, sourcing, statistical, subjectivity, SUNY, syndrome, therewith, topline, translocation, underwriting, USA, vi, viii, worker, Zausner
Filing tables
Filing exhibits
Related press release
Associated MCRB transcripts
MCRB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-273794) and S-8 (No. 333-205253, 333-210171, 333-223514, 333-230092, 333-236824, 333-253776, 333-263134, and 333-270319) of Seres Therapeutics, Inc. of our report dated March 5, 2024 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 5, 2024
1